M. G. Matera (Naples, Italy), G. Brusselle (Ghent, Belgium)
Effect of aclidinium bromide, a novel long-acting anticholinergic, on salivation, colonic motility and faecal output in different animal models J. L. Montero, F. Antón, M. Viñals, J. Gras, A. Gavaldà, J. Llenas (Barcelona, Spain)
| |
Potent anti-inflammatory effects of the highly selective iNOS inhibitor Byk402750 in a mouse model of cigarette smoke induced inflammation C. Hesslinger, M. L. Lehner, A. Strub, R. Boer, W. R. Ulrich, R. Kuelzer, G. Lauer, D. Liu, D. Spicer, M. Fitzgerald, L. Wollin, A. Weidenbach (Konstanz, Germany; Barcelona, Spain; London, United Kingdom)
| |
Aclidinium bromide, a novel long-acting anticholinergic drug, has a good preclinical cardiovascular safety profile J. Gras, A. Gavaldà, J. Llenas (Barcelona, Spain)
| |
The preclinical urinary and renal safety profile of aclidinium bromide, a novel long-acting anticholinergic drug J. Gras, J. Llupià, J. Llenas, A. Gavaldà (Barcelona, Spain)
| |
Rapid plasma hydrolysis of aclidinium bromide, a novel long-acting anticholinergic drug A. Gavaldà, S. Sentellas, J. Alberti, M. Miralpeix, F. Antón, M. Salvà, J. Beleta (Barcelona, Spain)
| |
The inhaled anticholinergic agent, aclidinium bromide, reverses cholinergic-induced bronchoconstriction in guinea pigs with a fast onset of action and a long duration of effect M. Miralpeix, C. Carreño, R. Otal, B. Reyes, C. Carcasona, J. Llenas, H. Ryder, J. Beleta, A. Gavaldà (Barcelona, Spain)
| |
Beneficial effects of autologous bone marrow mononuclear cell transplantation via the trachea against elastase-induced emphysema in rabbits Y. Ohno, H. Yuhgetsu, F. Ito, J. Endo, B. L. Bai La, K. Gotoh, H. Mori, S. Minatoguchi (Gifu, Japan)
| |
Single and repeated dose inhalation toxicology studies with alpha-1 proteinase inhibitor TAL6005 V. Arora, K. Bergstrand, J. Price, S. Petteway, P. Scuderi (Research Triangle Park, NC, United States Of America)
| |
Formoterol, but not salmeterol, restores corticosteroid sensitivity in peripheral blood mononuclear cells from COPD via PI3K inhibition C. Rossios, G. Osoata, P. Barnes, K. Ito (London, United Kingdom)
| |
Carrier-mediated disposal mechanisms for long-acting β2-agonists in the airway: the emerging role of corticosteroid sensitivity G. Horvath, N. Schmid, E. S. Mendes, A. Schmid, G. E. Conner, N. L. Fregien, M. Salathe, A. Wanner (Budapest, Hungary; Miami, United States Of America)
| |
New evidence of the effect of B-type natriuretic peptide (BNP) on human bronchi L. Calzetta, A. Sanduzzi, V. Parascandolo, M. Cazzola, M. G. Matera (Rome, Naples, Italy)
| |
The PDE4 inhibitor roflumilast N-oxide partly reversed TGFß1-induced changes in collagen I and E-cadherin expression in human airway epithelial cells J. Milara, J. Cortijo, M. Mata, E. Donet, M. Mauricio, E. Morcillo (Valencia, Spain)
| |
PGD2 induces constriction of the peripheral guinea pig lung via the TP receptor A. Hagfjärd, A. K. Larsson, M. Adner, S. E. Dahlén (Stockholm, Lund, Sweden)
| |
Interactions between angiotensin II and theophylline on isolated bronchi of normal and sensitized rats B. Gurzu, I. L. Dumitriu, B. C. Petrescu, B. M. Gurzu, M. Dinca, S. M. Slatineanu, M. Cosuleanu, G. Petrescu (Iasi, Romania)
| |
Effect of roflumilast, a PDE4 inhibitor, on ciliary beat frequency in human nasal epithelial cells J. Milara, J. Cortijo, M. Armengot, P. Bañuls, E. Gabarda, E. Morcillo (Valencia, Spain)
| |
Inhaled budesonide causes rapid vasoconstriction in the isolated and perfused rat lung P. Ewing, C. O. Sjöberg, P. Andersson, S. Edsbäcker, A. Ryrfeldt, P. Gerde (Lund, Stockholm, Sweden)
| |
Cyclooxygenase metabolites regulate airway smooth muscle response to PGE2 in guinea-pig trachea J. Säfholm, L. O. Cardell, S. E. Dahlén, M. Adner (Stockholm, Sweden)
| |
Peroxisome proliferator-activated receptor gamma antagonist, GW9662, inhibits microparticles generation by calcium ionophore-stimulated monocytes/macrophages T. Neri, Y. Carmazzi, A. Pegoli, M. C. Breschi, S. Fogli, P. Paggiaro, A. Celi (Pisa, Italy)
| |
Porcine alveolar epithelial primary cells (pAEpC) as a model for drug permeability assays H. Eixarch, A. Steimer, E. Haltner-Ukomadu, U. Bock (Saarbrücken, Germany)
| |